Stay updated on HBV Drug SB 9200 Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the HBV Drug SB 9200 Safety & Efficacy Clinical Trial page.

Latest updates to the HBV Drug SB 9200 Safety & Efficacy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page adds a Locations section with Alberta, British Columbia, Ontario, Gangwon-do, and Gyeongsangnam-do, and removes the corresponding location blocks; the HHS Vulnerability Disclosure link is also removed.SummaryDifference0.5%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.3.2 supersedes v3.3.1. No substantive study information or dates appear to have changed.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision: v3.3.1 was added and v3.2.0 was removed, a minor metadata update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedThe government funding status notice was removed from the Study Details page. This change does not affect trial details, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check60 days agoChange DetectedNo additions or deletions were detected for this study page; the content remains unchanged.SummaryDifference0.3%

- Check89 days agoChange Detected- Added a government funding notice and operating status guidance, plus a pointer to cc.nih.gov; - Bumped version from v3.1.0 to v3.2.0.SummaryDifference2%

Stay in the know with updates to HBV Drug SB 9200 Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HBV Drug SB 9200 Safety & Efficacy Clinical Trial page.